Physician

Eric D Popjes, MD

According to 2025 Medicare claims, Eric Popjes, MD (NPI: 1316905813) practices advanced heart failure and transplant cardiology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Dauphin, PA. This provider's primary affiliated billing organization is THE MILTON S HERSHEY MEDICAL CENTER PHYSICIANS GROUP (NPI: 1881669257; TIN: 251857035) and primary practice location at 17033-2360.

Popjes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 207 traditional Medicare patients, billed 476 HCPCS/CPT codes, and received $23,185 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,333 prescription claims across 152 beneficiaries totaling $608,393 in drug costs, led by Camzyos (Mavacamten). DME data shows 308 claims. Open Payments data shows 4 records totaling $23,286. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $44,749 to $23,185. In contrast, Part D prescription costs have moved sharply higher in recent years, from $93,045 to $608,393. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	283	781	$44,749
2016	325	687	$34,884
2017	360	878	$42,625
2018	289	760	$38,177
2019	260	765	$42,637
2020	251	507	$26,053
2021	216	570	$28,950
2022	238	478	$23,188
2023	211	520	$28,131
2024	207	476	$23,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	121	858	$93,045
2016	130	1,024	$117,005
2017	140	1,046	$129,817
2018	137	980	$134,724
2019	148	1,063	$157,066
2020	122	828	$142,721
2021	107	782	$132,944
2022	122	851	$146,554
2023	143	1,100	$532,972
2024	152	1,333	$608,393

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	137	$7,551
2017	22	158	$8,884
2018	N/R	121	$6,520
2019	24	170	$6,837
2020	N/R	57	$1,126
2021	N/R	42	$807
2022	N/R	175	$6,349
2023	12	393	$12,834
2024	N/R	308	$6,163

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	14	19	$99
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	24	142	$57
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	62	63	$46
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	75	90	$43
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	16	17	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Camzyos	Mavacamten	44	1,255	$327,096
Entresto	Sacubitril/Valsartan	46	2,662	$55,168
Eliquis	Apixaban	64	2,520	$47,087
Farxiga	Dapagliflozin Propanediol	23	1,890	$34,767
Veltassa	Patiromer Calcium Sorbitex	11	450	$21,535

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	54	$2,295
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	96	$1,129
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	59	$1,035
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	57	$668
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	30	$548

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$27	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$23,259	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric D. Popjes, MD?

Tedicare shows public-source Medicare data for Eric D. Popjes, MD (NPI 1316905813), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric D. Popjes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eric D. Popjes, MD?

Eric D. Popjes, MD is linked to THE MILTON S HERSHEY MEDICAL CENTER PHYSICIANS GROUP (billing NPI 1881669257) in the available physician profile data.

Does Eric D. Popjes, MD have Open Payments data?

Eric D. Popjes, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.